0638 FUNCTION AND WORK PRODUCTIVITY MEASURES IN A PHASE 3, RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, MULTICENTER, 12-WEEK STUDY OF THE SAFETY AND EFFICACY OF JZP-110 FOR THE TREATMENT OF EXCESSIVE SLEEPINESS IN PATIENTS WITH OBSTRUCTIVE SLEEP APNEA
Abstract Introduction: Excessive sleepiness in patients with obstructive sleep apnea (OSA) is associated with reductions in function and daily activities. JZP-110 is a selective dopamine norepinephrine reuptake inhibitor with wake-promoting effects. Effects of JZP-110 on function, work productivity,...
Gespeichert in:
Veröffentlicht in: | Sleep (New York, N.Y.) N.Y.), 2017-04, Vol.40 (suppl_1), p.A236-A236 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!